Specialization and integral vision, are the key of our success. From manufacture of the active pharmaceutical ingredient to development and commercialization of new products.
This allow us to offer our worldwide partners effective drugs for health care, chondroprotection and modulation of chronic inflammation, based on leading marketing strategies and medical-scientific research programs adapted to each market.
Bioiberica researches, develops, manufactures and markets the most important chondroprotectors molecules (Chondroitin, Glucosamine and Hyaluronic Acid).
Our constant dedication to scientific research, numerous published clinical studies and research projects already started in this field, has allowed us to support a leading position, indisputable in spanish pharmaceutical market of chondroprotection.
Internationally we are present with our network of licensees and/or distributors.
For more information about our products lines and license possibilities, contact us.